Endpoint Health is a Health Care startup founded in 2018 with the slogan "Precision immunology therapies." The company is dedicated to addressing unmet needs in immune-mediated chronic and acute diseases. Leveraging a proprietary artificial intelligence (AI) platform, Endpoint Health combines companion diagnostics with therapeutics to develop precision therapies. Their vision is to create a world in which all patients receive the best treatment possible for their unique biology and disease. The startup, headquartered in the United States, received a Debt Financing investment on 02 June 2022. This investment signifies potential growth and recognition from the investment market.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series A | $52.00M | 10 | Mayfield Fund, Global Health Investment Fund (GHIF) +1 | 02 Jun 2022 |
Debt Financing | Unknown | - | 02 Jun 2022 | |
Series A | Unknown | 4 | Milad Alucozai | 09 Feb 2022 |
Debt Financing | Unknown | - | 13 Jul 2020 | |
Venture Round | $12.00M | 5 | Mayfield Fund, Ali Tamaseb | 13 Jul 2020 |
No recent news or press coverage available for ENDPOINT HEALTH.